Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
SaNOtize
AddedMay 19, 2026
UpdatedMay 31, 2026
SaNOtize

SaNOtize

Series B

Canadian pharmaceutical company developing nitric oxide-based therapeutics for infectious diseases.

HQ
Vancouver, BC, CA
Founded
2017
Overview
Compare
Fundraising
Employees
News
Website

SaNOtize is a global pharmaceutical company founded in 2017 in Vancouver, Canada, that developed a disruptive first-in-class technology to deliver the natural properties and advantages of nitric oxide. Its lead product, NONS, is a nitric oxide nasal spray shown in clinical studies to treat and prevent COVID-19 with a 94% reduction in viral burden within 24 hours.

The company raised a $24 million Series B in August 2022 co-led by Horizons Ventures and OurCrowd. SaNOtize is led by CEO Mikael Svensson, a seasoned executive with over 25 years of experience in consumer health and pharmaceuticals, and CFO Gibb Clarke, who has raised over $450M in investment capital across his career.

SaNOtize - Similar Companies

Noxsano logo

Noxsano

noxsano.com

Noxilizer logo

Noxilizer

noxilizer.com

Hansen Pharmaceutical logo

Hansen Pharmaceutical

hansenpharma.com

Nota Labs logo

Nota Labs

notalabs.com

Nitric Bio logo

Nitric Bio

Vast Therapeutics logo

Vast Therapeutics

Sano Chemicals logo

Sano Chemicals

sanochemicals.com

Know Bio logo

Know Bio

knowbiollc.com

Saje Pharma logo

Saje Pharma

sajepharma.com

SaiOx logo

SaiOx

saiox.com

Nasus Medical logo

Nasus Medical

nasusmedical.com

Vero Biotech logo

Vero Biotech

vero-biotech.com

Nitrase Therapeutics logo

Nitrase Therapeutics

nitrasetx.com

Beyond Air logo

Beyond Air

beyondair.net

It's Nanoed logo

It's Nanoed

SaNOtize - Quick Facts

Who are SaNOtize's competitors?

Companies similar to SaNOtize include Noxsano, Noxilizer, Hansen Pharmaceutical and Nota Labs.

When was SaNOtize founded?

SaNOtize was founded in 2017.

Where is SaNOtize's headquarters located?

SaNOtize's headquarters is located in Vancouver, BC, CA.

How much has SaNOtize raised to-date?

As of the latest available date, SaNOtize has raised a total of $24M (USD)

SaNOtize - Classification

Industry
  • Pharmaceuticals
Tags
  • Biotechnology
  • Infectious Disease
  • Nitric Oxide Therapeutics